0001144204-13-000559.txt : 20130103 0001144204-13-000559.hdr.sgml : 20130103 20130103183530 ACCESSION NUMBER: 0001144204-13-000559 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20130102 FILED AS OF DATE: 20130103 DATE AS OF CHANGE: 20130103 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Snyder Scott A. CENTRAL INDEX KEY: 0001565556 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-32715 FILM NUMBER: 13508968 MAIL ADDRESS: STREET 1: C/O INTERLEUKIN GENETICS, INC. STREET 2: 135 BEAVER STREET CITY: WALTHAM STATE: MA ZIP: 02452 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: INTERLEUKIN GENETICS INC CENTRAL INDEX KEY: 0001037649 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 943123681 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 135 BEAVER ST CITY: WATHAM STATE: MA ZIP: 02452 BUSINESS PHONE: 1-781-398-0700 MAIL ADDRESS: STREET 1: 135 BEAVER ST CITY: WATHAM STATE: MA ZIP: 02452 FORMER COMPANY: FORMER CONFORMED NAME: MEDICAL SCIENCE SYSTEMS INC DATE OF NAME CHANGE: 19971003 4 1 v331378_form4.xml OWNERSHIP DOCUMENT X0306 4 2013-01-02 0 0001037649 INTERLEUKIN GENETICS INC ILIU 0001565556 Snyder Scott A. C/O INTERLEUKIN GENETICS, INC. 135 BEAVER STREET WALTHAM MA 02452 0 1 0 0 Chief Marketing Officer Stock Option (Right to Buy) 0.29 2013-01-02 4 A 0 200000 0 A 2023-01-02 Common Stock 200000 200000 D The exercise price of the option is the closing price of the Issuer's common stock on the OTCQB on 01/02/2013, which was the grant date of the option. The option vests as to 50,000, 66,000 and 84,000 shares on the first, second and third anniversaries of the grant date, respectively. /s/ Brian P. Keane, Attorney-in-fact 2013-01-03